Integra Lifesciences Holdings Corp (IART): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of IART were reported in the last 12 months. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Integra Lifesciences Holdings
From the latest filingsOverall: more buying than selling. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns IART
211 funds and institutions reported IART shares worth $1.3B at the end of Q2 2026, about 96% of the company. The largest holder is BlackRock, Inc. with 13.7%.
Funds and institutions (13F) 96%Everyone else 4%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 10.68M | 13.73% | $192M | +4% |
| Rubric Capital Management LP | 7.75M | 9.97% | $139M | No change |
| Invesco Ltd. | 3.75M | 4.82% | $67.3M | +8% |
| Vanguard Portfolio Management LLC | 3.74M | 4.81% | $67.2M | +2% |
| Morgan Stanley | 3.59M | 4.62% | $64.5M | +0% |
| Paradigm Capital Management Inc | 3.44M | 4.42% | $61.8M | -14% |
| Fuller & Thaler Asset Management, Inc. | 3.44M | 4.42% | $61.7M | -3% |
| State Street Corp | 2.95M | 3.79% | $52.9M | +2% |
| Vanguard Capital Management LLC | 2.95M | 3.79% | $52.9M | +2% |
| Neuberger Berman Group LLC | 2.36M | 3.04% | $42.6M | +12% |
| Dimensional Fund Advisors LP | 2.22M | 2.85% | $39.8M | -20% |
| Geode Capital Management, LLC | 1.79M | 2.30% | $32.2M | +8% |
| Goldman Sachs Group Inc | 1.47M | 1.89% | $26.5M | -21% |
| Wellington Management Group LLP | 1.46M | 1.88% | $26.2M | +12% |
| Millennium Management LLC | 1.44M | 1.85% | $25.9M | +131% |
| Charles Schwab Investment Management Inc | 1.40M | 1.80% | $25.2M | -13% |
| Sixth Street Partners Management Company, L.P. | 1.40M | 1.80% | $25.2M | – |
| Bank of America Corp | 1.33M | 1.71% | $23.9M | -6% |
| Systematic Financial Management LP | 1.02M | 1.32% | $18.4M | -3% |
| Allianz Asset Management GmbH | 1.01M | 1.29% | $18.1M | +13% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No IART insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
IART short interest
High short interest. 10.1% of IART shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went down 14%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7.90M IART shares were sold short, 10.1% of the shares outstanding, up 7.9% from the report before. At the average daily volume of 1.24M shares, buying them all back would take about 6.4 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7.90M | 10.15% | +8% | 1.24M | 6.4 |
| Oct 15, 2026 | 7.32M | 9.41% | +1% | 1.33M | 5.5 |
| Sep 30, 2026 | 7.27M | 9.34% | +7% | 967,947 | 7.5 |
| Sep 15, 2026 | 6.81M | 8.75% | -1% | 823,984 | 8.3 |
| Aug 31, 2026 | 6.86M | 8.82% | +2% | 557,304 | 12.3 |
| Aug 14, 2026 | 6.74M | 8.67% | +4% | 677,615 | 9.9 |
| Jul 31, 2026 | 6.48M | 8.33% | +4% | 1.11M | 5.8 |
| Jul 15, 2026 | 6.21M | 7.98% | -3% | 865,084 | 7.2 |
| Jun 30, 2026 | 6.39M | 8.22% | -11% | 1.12M | 5.7 |
| Jun 15, 2026 | 7.22M | 9.28% | -10% | 833,911 | 8.7 |
| May 29, 2026 | 7.99M | 10.26% | -13% | 988,502 | 8.1 |
| May 15, 2026 | 9.20M | 11.83% | -1% | 1.51M | 6.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Integra Lifesciences Holdings company events
Integra Lifesciences Holdings filed 12 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Oct 21, 2026.
- Oct 21, 2026ResultsReleased financial results. Filing
- Oct 19, 2026AgreementIntegra LifeSciences Holdings Corporation entered into an amended and restated credit agreement with a syndicate of lending banks, and Bank of America, N.A., as Administrative Agent, Swing Line Lender and a L/C Issuer. Filing
- Oct 9, 2026AnnouncementShared information with investors. Filing
- Oct 2, 2026ResultsReleased financial results. Filing
- Sep 8, 2026AnnouncementShared information with investors. Filing
- Jul 29, 2026ResultsReleased financial results. Filing
- May 8, 2026LeadershipIntegra LifeSciences Holdings Corporation held its 2026 Annual Meeting of Stockholders on May 7, 2026. Filing
- May 5, 2026LeadershipIntegra LifeSciences Holdings Corporation announced the appointment of Dr. Stuart M. Essig to serve as its President and Chief Executive Officer, effective as of May 1, 2026. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Apr 15, 2026AgreementAs previously disclosed, on December 18, 2018, certain subsidiaries of Integra LifeSciences Holdings Corporation, a Delaware corporation, entered into a $150 million accounts receivable securitization facility to reduce outstanding revolving borrowings under the Company’s senior credit facility and… Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Dec 12, 2025LeadershipIntegra LifeSciences Holdings Corporation adopted a change in control severance program under which certain executives of the Company, including Lea Knight, Executive Vice President and Chief Financial Officer, Robert T. Davis, Jr., Executive Vice President, President – Tissue Technologies, Michael… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Integra Lifesciences Holdings financials
Famous investors that hold IART
3 of the 50 well-known investors we track reported holding IART in their latest 13F filing. The largest position is Ken Griffin's, worth $8.9M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 544,167 | $8.9M | 0.0% | New |
| Israel Englander · Millennium Management | Q3 2026 | 430,391 | $7M | 0.0% | -70% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 108,684 | $1.8M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named IART in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 10, 2026 | Invesco Ltd. | 13G | 5.4% |
| Nov 10, 2026 | Invesco Ltd. | 13G | 5.4% |
Questions about Integra Lifesciences Holdings Corp (IART) stock
Who owns the most IART stock?
The largest reported owner of Integra Lifesciences Holdings Corp (IART) is BlackRock, Inc., with 13.7% of the company. In total, 211 funds and institutions reported holding IART at the end of Q2 2026, together about 96% of the shares. See the largest owners.
Are IART insiders buying or selling?
No IART insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in IART?
As of Oct 30, 2026, 7.90M IART shares were sold short, 10.1% of the shares outstanding, up 7.9% from the report before. At the average daily volume of 1.24M shares, buying them all back would take about 6.4 trading days (days to cover). See the history.
Which famous investors hold IART?
3 of the 50 well-known investors we track reported IART in their latest 13F filing, including Ken Griffin, Israel Englander, Paul Tudor Jones. The largest position is worth $8.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.